Australian startups take on big pharma with precision cancer breakthroughs
Radiopharma therapies targeting prostate cancer are driving a new gold rush in biotech—and Australia is leading the charge.| Forbes Australia
Radiopharma therapies targeting prostate cancer are driving a new gold rush in biotech—and Australia is leading the charge.| Forbes Australia
